Innovative MedTech, Inc.
IMTH
$0.042
-$0.0424-50.24%
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -94.72% | 5.74% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -94.72% | -14.41% | |||
| Operating Income | 94.72% | -29.94% | |||
| Income Before Tax | 89.40% | -25.52% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 89.40% | -25.52% | |||
| Earnings from Discontinued Operations | 288.24% | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 92.10% | -27.26% | |||
| EBIT | 94.72% | -29.94% | |||
| EBITDA | 95.84% | -30.28% | |||
| EPS Basic | 95.33% | -14.11% | |||
| Normalized Basic EPS | 93.75% | -12.56% | |||
| EPS Diluted | 95.33% | -14.11% | |||
| Normalized Diluted EPS | 93.75% | -12.56% | |||
| Average Basic Shares Outstanding | 70.54% | 11.44% | |||
| Average Diluted Shares Outstanding | 70.54% | 11.44% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||